The Valley Desk

NCT05843253 · Interventional trial

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Overall registry status Recruiting

Phase 2

Conditions Anaplastic Astrocytoma, Diffuse Hemispheric Glioma, H3 G34-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Glioblastoma, Glioblastoma Multiforme, High Grade Glioma, Metastatic Brain Tumor, WHO Grade III Glioma, WHO Grade IV Glioma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov